Published in J Int AIDS Soc on June 05, 2017
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature (2001) 14.24
T cell exhaustion. Nat Immunol (2011) 11.08
Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis (2004) 9.73
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell (2013) 6.47
Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine (2012) 6.01
Global burden of human papillomavirus and related diseases. Vaccine (2012) 5.48
Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol (2014) 4.82
HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science (2014) 3.47
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis (2009) 3.39
HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science (2014) 3.17
Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med (2006) 3.09
Improvement of pathology in sub-Saharan Africa. Lancet Oncol (2013) 2.88
Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol (2012) 2.84
The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis (2001) 2.79
Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol (2015) 2.74
HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep (2012) 2.71
Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One (2015) 2.68
Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis. Clin Infect Dis (2014) 2.55
Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies. J Infect Dis (2015) 2.52
Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med (2013) 2.47
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS (2011) 2.43
The interaction between nutrition and infection. Clin Infect Dis (2008) 2.39
Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Med (2013) 2.38
Microbial translocation across the GI tract. Annu Rev Immunol (2012) 2.30
Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis (2009) 2.30
Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hyg (2012) 2.27
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One (2015) 2.26
Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity (2015) 2.05
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev (2004) 1.95
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis (2012) 1.86
Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J Virol (2008) 1.79
A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog (2014) 1.78
Memory T cell homeostasis and senescence during aging. Curr Opin Immunol (2005) 1.75
Towards an HIV-1 cure: measuring the latent reservoir. Trends Microbiol (2015) 1.73
The origin and diversity of the HIV-1 pandemic. Trends Mol Med (2012) 1.65
Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J Clin Microbiol (2007) 1.60
CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue. J Immunol (2007) 1.58
Gastroenterology in developing countries: issues and advances. World J Gastroenterol (2009) 1.53
Editorial commentary: immunodeficiency at start of antiretroviral therapy: the persistent problem of late presentation to care. Clin Infect Dis (2014) 1.51
Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest (2011) 1.49
Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat Med (2016) 1.48
Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr (2011) 1.45
Expanded polyfunctional T cell response to mycobacterial antigens in TB disease and contraction post-treatment. PLoS One (2010) 1.44
Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals. J Immunol (2010) 1.42
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals. EBioMedicine (2015) 1.42
Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog (2014) 1.30
International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med (2016) 1.29
Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res Hum Retroviruses (2010) 1.26
The immune system in children with malnutrition--a systematic review. PLoS One (2014) 1.22
Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function. J Infect Dis (2000) 1.22
Correlates of HIV-1 genital shedding in Tanzanian women. PLoS One (2011) 1.19
Social and ethical implications of HIV cure research. AIDS (2014) 1.14
T-cell regulation in helminth parasite infections: implications for inflammatory diseases. Chem Immunol Allergy (2008) 1.14
Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. PLoS Pathog (2011) 1.14
Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa. AIDS (2014) 1.12
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption. Nat Commun (2015) 1.10
A hardwired HIV latency program. Cell (2015) 1.08
Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol Rev (2014) 1.08
From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication. Bioessays (2013) 1.07
PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals. Nat Med (2016) 1.04
Words matter: Discussing research towards an HIV cure in research and clinical contexts. J Acquir Immune Defic Syndr (2014) 1.04
Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis. PLoS One (2014) 1.04
Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome. Cell Host Microbe (2016) 1.04
Very early combination antiretroviral therapy in infants: prospects for cure. Curr Opin HIV AIDS (2015) 1.02
Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012. PLoS One (2015) 1.00
T cell exhaustion during persistent viral infections. Virology (2015) 1.00
CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells. PLoS One (2014) 0.99
Stakeholder Engagement in HIV Cure Research: Lessons Learned from Other HIV Interventions and the Way Forward. AIDS Patient Care STDS (2015) 0.99
Building capacity for sustainable research programmes for cancer in Africa. Nat Rev Clin Oncol (2014) 0.94
Impact of highly active antiretroviral therapy initiation on CD4(+) T-cell repopulation in duodenal and rectal mucosa. AIDS (2013) 0.91
Germinal Center T Follicular Helper Cells Are Highly Permissive to HIV-1 and Alter Their Phenotype during Virus Replication. J Immunol (2016) 0.91
Initiation of antiretroviral therapy in early HIV infection reduces but does not abrogate chronic residual inflammation. Clin Infect Dis (2016) 0.91
Residual inflammation and viral reservoirs: alliance against an HIV cure. Curr Opin HIV AIDS (2016) 0.90
HIV-1 LTR subtype and perinatal transmission. Virology (2001) 0.90
A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis (2015) 0.88
Immune activation during acute HIV infection and the impact of early antiretroviral therapy. Curr Opin HIV AIDS (2016) 0.88
Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA. J Clin Microbiol (2016) 0.86
Pattern of microbial translocation in patients living with HIV-1 from Vietnam, Ethiopia and Sweden. J Int AIDS Soc (2014) 0.86
Genital inflammation, immune activation and risk of sexual HIV acquisition. Curr Opin HIV AIDS (2016) 0.85
Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era. Front Microbiol (2015) 0.84
Latent and Active Tuberculosis Infection Increase Immune Activation in Individuals Co-Infected with HIV. EBioMedicine (2015) 0.84
CNS reservoirs for HIV: implications for eradication. J Virus Erad (2015) 0.83
Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection. J Virol (2016) 0.82
Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection. J Acquir Immune Defic Syndr (2016) 0.82
TFH in HIV Latency and as Sources of Replication-Competent Virus. Trends Microbiol (2016) 0.82
Malnutrition and vaccination in developing countries. Philos Trans R Soc Lond B Biol Sci (2015) 0.81
Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa. J Infect Dis (2016) 0.80
Reversal of T-cell exhaustion as a strategy to improve immune control of HIV-1. AIDS (2015) 0.80
Coincident helminth infection modulates systemic inflammation and immune activation in active pulmonary tuberculosis. PLoS Negl Trop Dis (2014) 0.79
Investigation of Neuropathogenesis in HIV-1 Clade B and C Infection Associated with IL-33 and ST2 Regulation. ACS Chem Neurosci (2015) 0.78
Quadruple burden of HIV/AIDS, tuberculosis, chronic intestinal parasitoses, and multiple micronutrient deficiency in ethiopia: a summary of available findings. Biomed Res Int (2015) 0.78
Dysfunctional adaptive immunity during parasitic infections. Curr Immunol Rev (2013) 0.78
Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1. AIDS Res Hum Retroviruses (2016) 0.77
Plasma Levels of Neopterin and C-Reactive Protein (CRP) in Tuberculosis (TB) with and without HIV Coinfection in Relation to CD4 Cell Count. PLoS One (2015) 0.77
Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected Late Presenters. Chin Med J (Engl) (2016) 0.77
Introduction to a Special Issue of the Journal of Immunological Methods: Building global resource programs to support HIV/AIDS clinical trial studies. J Immunol Methods (2014) 0.77
Autophagy in Mycobacterium tuberculosis and HIV infections. Front Cell Infect Microbiol (2015) 0.77
Longitudinal changes in total, 2-LTR circular, and integrated HIV-1 DNA during the first year of HIV-1 infection in CD4Low and CD4High patient groups with HIV-1 subtype AE. Viral Immunol (2014) 0.77
Vitamin D Status in South Africa and Tuberculosis. Lung (2015) 0.77